Imbio RV/LV Software vs AVIEW
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 68/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A specializes in automated right and left ventricular measurements from CTPA scans, primarily for pulmonary embolism risk stratification. Tool B provides a broader AI platform for lung cancer screening, COPD assessment, and coronary artery calcification scoring from CT scans. While both operate within radiology, cardiology, and pulmonology, their core functionalities and specific diagnostic focuses are distinct.
Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your primary need is rapid, automated assessment of right and left ventricular dimensions and their ratio from CTPA scans. This tool is ideal for aiding in the risk stratification of patients with acute pulmonary conditions, such as suspected pulmonary embolism, where quick and accurate cardiac strain assessment is critical.
View Imbio RV/LV Software →Choose AVIEW if…
Choose AVIEW if you require a comprehensive AI platform for multi-faceted thoracic CT analysis, including early detection and monitoring of lung cancer, COPD, and coronary artery calcification. This solution is best suited for programs focused on broad-spectrum lung health screening, detailed emphysema quantification, and cardiovascular risk assessment from a single CT scan.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio RV/LV Software | AVIEW |
|---|---|---|
| Pricing | Unknown | Subscription; one-off payment |
| Deployment | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio RV/LV Software | AVIEW |
|---|---|---|
| Primary Focus | Automated measurement of right and left ventricular diameters from CTPA scans for risk stratification in pulmonary conditions like pulmonary embolism. | Comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans. |
| Cardiology AI Features | Automated measurement of right and left ventricular diameters, calculation and reporting of RV/LV ratio. | Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification), automated segmentation of coronary arteries. |
| Pulmonology AI Features | Aids in risk stratification for pulmonary conditions like pulmonary embolism (indirectly via RV/LV ratio). | AI-powered lung nodule detection and characterization, emphysema quantification and low attenuation area (LAA) analysis, automated segmentation of lung lobes, airways, vessels, Interstitial Lung Disease (ILD) pattern analysis. |
| Reporting Capabilities | Generates summary PDF reports, provides annotated images showing ventricular measurements. | 3D visualizations and comprehensive PDF reports. |
| Workflow Integration | DICOM compliant input and output, integration with standard reading environments (PACS). | Workflow automation and integration with PACS/RIS/CIS, follow-up registration and nodule matching for serial CT scans. |
Videos
Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and AVIEW.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Imbio RV/LV Software is an AI-powered tool designed to automatically measure right and left ventricular diameters from CTPA scans, providing an RV/LV ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. AVIEW, on the other hand, offers comprehensive AI solutions for the early detection, diagnosis, and monitoring of lung cancer (including nodule detection, characterization, and Lung-RADS scoring), COPD (emphysema quantification and low attenuation area analysis), and coronary artery calcification (CAC scoring) from CT scans, and also includes Interstitial Lung Disease (ILD) pattern analysis.
Imbio RV/LV Software specifically measures right and left ventricular diameters from CTPA scans and calculates their ratio (RV/LV ratio) to assess ventricular strain. AVIEW provides coronary artery calcium (CAC) scoring, including Agatston, volume, and mass scores, for risk stratification, and also performs automated segmentation of coronary arteries.
Imbio RV/LV Software focuses on automated initial measurements and reporting of RV/LV ratios. AVIEW includes specific features for follow-up registration and nodule matching for serial CT scans, which is beneficial for monitoring conditions like lung cancer.
Imbio RV/LV Software is DICOM compliant for input and output and integrates with standard reading environments (PACS), also being available via various partner platforms. AVIEW offers workflow automation and integration with PACS, RIS, and CIS.